Purchase Order 75H71023P00542

Award Date 2/16/23
Potential Completion Date 4/8/25
Potential Value $544K
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Indian Health Service awarded a firm fixed price delivery order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of COVID-19 testing kits (Cepheid 4PLEX XP3COV2 FLU RSV-10). The $204,000 award does not have a set-aside designation and is in support of the agency's Coronavirus COVID-19 response efforts. Cepheid, a subsidiary of Danaher Corporation, has a history of providing diagnostic testing equipment,...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of COVID-19 test kits to the Department of Health and Human Services Indian Health Service. The firm fixed-price contract has a potential value of $173,730.00 and is set to be completed by April 5, 2023. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the Indian Health...
This is a firm fixed-price purchase order contract awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $710,600.00, is for the provision of COVID-19 test kits from Cepheid on an "as needed" basis, with a period of performance through December 31, 2023. The contract does not have a set-aside designation. Cepheid is a...
This federal contract award was issued by the Department of Health and Human Services Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $136,000.00 firm fixed-price delivery order is for COVID-19 test kits and related control materials. The award does not have a set-aside designation. Cepheid, a subsidiary of Danaher Corporation, has received numerous federal contracts and grants to support the diagnostic programs of agencies like the Department...
The Department of Health and Human Services Indian Health Service awarded a $367,200.00 firm fixed price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID 4-PLEX COVID-19 TESTING KITS. The contract has a completion date of December 27, 2021 and was awarded on December 28, 2020. This award was not set aside. Cepheid is the prime contractor and no major subcontractors are mentioned. The contract supports the Indian Health...
The Department of Health and Human Services Indian Health Service awarded a firm fixed price delivery order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID 4PLEX+ COVID-19 TESTING KITS. The $136,000.00 award has a completion date of July 30, 2022 and is not associated with a set-aside program. Cepheid, a subsidiary of Danaher Corporation, has a history of providing diagnostic testing equipment, reagents, and consumables to federal agencies such as...
The Department of Health and Human Services Indian Health Service awarded a firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $136,000 contract modification adds a new COVID-19 testing option to Cepheid's existing agency-wide Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Cepheid, a subsidiary of Danaher Corporation, is a major supplier of reagents, test kits, instruments, and testing platforms to support the clinical...
This is a federal contract award from the Indian Health Service (IHS), a civilian agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the supply of COVID-19 test kits, with a ceiling value of $294,910.00 and a period of performance ending on November 30, 2020. This appears to be a standalone purchase order and was not set aside for any specific business type. The contract award indicates that Cepheid has a history of providing diagnostic equipment...
The U.S. Indian Health Service (IHS) awarded a $115,600.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID TEST KITS. The contract has an ultimate completion date of July 10, 2025 and was awarded on January 30, 2024. Cepheid is a prime contractor that provides advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing to various federal agencies,...
This federal contract award to Cepheid, a for-profit manufacturer of diagnostic solutions, is for the purchase of analyzers, related equipment, supplies, and services to support COVID-19 testing and patient care for the Department of Health and Human Services (HHS) Indian Health Service. The $297,270.00 fixed-price delivery order does not utilize a set-aside designation. As the prime contractor, Cepheid will provide reagents, test kits, instruments, and testing platforms to the Indian Health...

The U.S. Indian Health Service awarded a $544,000.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, to provide COVID-19 test kits. This contract has no set-aside designation. Cepheid has previously received awards from federal agencies, including the Department of Veterans Affairs and the Defense Logistics Agency, to supply diagnostic testing equipment, reagents, and consumables. The company has also participated as a subcontractor on federal grant projects focused on improving tuberculosis diagnostics globally.

Generated 4/9/25, 10:44 AM